Equities

Poxel SA

Poxel SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.565
  • Today's Change0.011 / 1.99%
  • Shares traded168.37k
  • 1 Year change+13.45%
  • Beta1.2741
Data delayed at least 15 minutes, as of Sep 20 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Poxel SA share price to rise to 3.50 in the next year from the last price of 0.554.
High531.8%3.50
Med531.8%3.50
Low531.8%3.50

Earnings history & estimates in EUR

Earnings forecasts are not available for Poxel SA. On Sep 09, 2024, Poxel SA reported 4th quarter 2023 losses of -- per share.
Average growth rate-79.31%
Annual earnings information is not available for Poxel SA.
Average growth rate-5.67%
More ▼

Revenue history & estimates in EUR

Poxel S.A. had 4th quarter 2023 revenues of 362.00k. This was 1,031.25% above the prior year's 4th quarter results.
Average growth rate+34.32%
Poxel S.A. had revenues for the full year 2023 of 1.98m. This was 193.92% above the prior year's results.
Average growth rate+30.35%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.